v3.26.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Mar. 31, 2026
Dec. 31, 2025
Current Assets:    
Cash $ 38,887 $ 204,725
Accounts receivable 15,624 5,110
Other receivable 302,500 302,500
Inventory 24,430 24,430
Prepaid expenses 66,818 170,257
Deferred offering costs 460,915
Other current assets 447,329 76,166
Total Current Assets 1,356,503 783,188
Property and Equipment, net of depreciation 1,974,467 2,022,043
Patents, net of amortization 1,995,774 1,991,623
Total Assets 5,326,744 4,796,854
Current Liabilities:    
Accounts payable and accrued expenses 5,553,222 3,509,936
Excise tax payable 1,060,321 964,463
Derivative liabilities 4,211,250 4,772,600
Short-term notes payable 2,607,666 2,647,556
Total Liabilities 13,595,332 11,982,428
Commitments and contingencies (Note 6)
Stockholders’ Deficit:    
Preferred stock, $0.0001 par value; 2,000,000 shares authorized; none issued and outstanding
Common stock, $0.0001 par value, 300,000,000 shares authorized, 7,745,683 and 7,465,283 issued and outstanding as of March 31, 2026 and December 31, 2025, respectively 774 746
Additional paid-in capital 159,453,519 159,027,646
Stock subscription receivable (2,919,674) (2,841,427)
Accumulated deficit (164,803,207) (163,372,539)
Total Stockholders’ Deficit (8,268,588) (7,185,574)
Total Liabilities and Stockholders’ Deficit 5,326,744 4,796,854
Related Party    
Current Liabilities:    
Due to related party $ 162,873 $ 87,873